lilly retatrutide trial VisualAbstract: reduces body weight by 17.5% in patients with obesity Retatrutide Meets Phase 3 Weight-Loss

The symptom indicates your medication is actively working, not failing

That number could increase significantly over time as supply shortages of the drug are resolved, as indications for the drugs expand, and especially if health-insurance companies increase coverage for the drugs.

Mojsov points out that the speed with which this happened was because 'At that time you didn't need to get FDA approval for clinical studies of the material being tested at the same institution where the studies were carried out

That also means side effects at higher doses are real, and earning your dose over time is not optional it's the strategy

References Engeln-Maddox, R

This accumulation facilitates the binding of -catenin to TCF7L12, triggering the activation of genes associated with osteogenesis